ScoreWhy is Nath Bio-Genes (India) Ltd ?
1
Weak Long Term Fundamental Strength with a 1.96% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 6.19% signifying low profitability per unit of shareholders funds
2
Flat results in Mar 26
- PAT(9M) At Rs 2.85 cr has Grown at -45.70%
- INTEREST(Latest six months) At Rs 9.13 cr has Grown at 33.09%
- NON-OPERATING INCOME(Q) is 193.50 % of Profit Before Tax (PBT)
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -7.09% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Nath Bio-Genes should be less than 10%
- Overall Portfolio exposure to Other Agricultural Products should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Nath Bio-Genes for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Nath Bio-Genes
-16.33%
-0.19
38.04%
Sensex
-5.12%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.88%
EBIT Growth (5y)
1.96%
EBIT to Interest (avg)
4.33
Debt to EBITDA (avg)
2.42
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.48
Tax Ratio
10.08%
Dividend Payout Ratio
9.85%
Pledged Shares
13.78%
Institutional Holding
0.24%
ROCE (avg)
6.73%
ROE (avg)
6.19%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
8
Industry P/E
13
Price to Book Value
0.47
EV to EBIT
7.84
EV to EBITDA
7.24
EV to Capital Employed
0.51
EV to Sales
0.85
PEG Ratio
8.17
Dividend Yield
1.20%
ROCE (Latest)
6.53%
ROE (Latest)
5.71%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
NET SALES(Latest six months)
At Rs 117.55 cr has Grown at 32.32%
ROCE(HY)
Highest at 6.87%
DEBTORS TURNOVER RATIO(HY)
Highest at 5.21 times
-11What is not working for the Company
PAT(9M)
At Rs 2.85 cr has Grown at -45.70%
INTEREST(Latest six months)
At Rs 9.13 cr has Grown at 33.09%
NON-OPERATING INCOME(Q)
is 193.50 % of Profit Before Tax (PBT
EPS(Q)
Lowest at Rs -0.01
Loading Valuation Snapshot...
Here's what is working for Nath Bio-Genes
Net Sales - Latest six months
At Rs 117.55 cr has Grown at 32.32%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Debtors Turnover Ratio- Half Yearly
Highest at 5.21 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Nath Bio-Genes
Profit After Tax (PAT) - Nine Monthly
At Rs 2.85 cr has Grown at -45.70%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Interest - Latest six months
At Rs 9.13 cr has Grown at 33.09%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Non Operating Income - Quarterly
is 193.50 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
Earnings per Share (EPS) - Quarterly
Lowest at Rs -0.01
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
